世界科学技术-中医药现代化
世界科學技術-中醫藥現代化
세계과학기술-중의약현대화
WORLD SCIENCE AND TECHNOLOGY-MODERNIZATION OF TRADITIONAL CHINESE MEDICINE
2015年
6期
1235-1242
,共8页
宫晓洋%战丽彬%隋华%梁丽娜%王健
宮曉洋%戰麗彬%隋華%樑麗娜%王健
궁효양%전려빈%수화%량려나%왕건
脾阴虚痴呆%滋补脾阴方药%NR1%NR2A%NR2B
脾陰虛癡呆%滋補脾陰方藥%NR1%NR2A%NR2B
비음허치태%자보비음방약%NR1%NR2A%NR2B
Spleen-yin deficiency Alzheimer's disease%Zi-Bu Pi-Yin recipe%NR1%NR2A%NR2B
目的:观察滋补脾阴方药对脾阴虚痴呆大鼠脑内N-甲基-D-天冬氨酸受体(NMDAR)亚单位NR1、NR2A、NR2B mRNA表达的影响。方法:运用逆转录聚合酶链反应(RT-PCR)技术,对NMDAR亚单位NR1、NR2A、NR2B mRNA在各脑区的表达状况作相应的检测。结果:痴呆组以及脾阴虚痴呆组大鼠NMDAR亚单位NR1、NR2A、NR2B mRNA在各脑区表达均明显减弱下调(P<0.05);ZBPYR治疗组NMDAR亚单位NR1、NR2A、NR2B mRNA均明显上调(P<0.05)。结论:使用ZBPYR治疗的大鼠NMDAR mRNA的表达水平在各脑区均明显上调,这表明ZBPYR以提升NMDAR mRNA的方式,使得NMDAR蛋白的含量显著增多,而发挥其抗痴呆作用。
目的:觀察滋補脾陰方藥對脾陰虛癡呆大鼠腦內N-甲基-D-天鼕氨痠受體(NMDAR)亞單位NR1、NR2A、NR2B mRNA錶達的影響。方法:運用逆轉錄聚閤酶鏈反應(RT-PCR)技術,對NMDAR亞單位NR1、NR2A、NR2B mRNA在各腦區的錶達狀況作相應的檢測。結果:癡呆組以及脾陰虛癡呆組大鼠NMDAR亞單位NR1、NR2A、NR2B mRNA在各腦區錶達均明顯減弱下調(P<0.05);ZBPYR治療組NMDAR亞單位NR1、NR2A、NR2B mRNA均明顯上調(P<0.05)。結論:使用ZBPYR治療的大鼠NMDAR mRNA的錶達水平在各腦區均明顯上調,這錶明ZBPYR以提升NMDAR mRNA的方式,使得NMDAR蛋白的含量顯著增多,而髮揮其抗癡呆作用。
목적:관찰자보비음방약대비음허치태대서뇌내N-갑기-D-천동안산수체(NMDAR)아단위NR1、NR2A、NR2B mRNA표체적영향。방법:운용역전록취합매련반응(RT-PCR)기술,대NMDAR아단위NR1、NR2A、NR2B mRNA재각뇌구적표체상황작상응적검측。결과:치태조이급비음허치태조대서NMDAR아단위NR1、NR2A、NR2B mRNA재각뇌구표체균명현감약하조(P<0.05);ZBPYR치료조NMDAR아단위NR1、NR2A、NR2B mRNA균명현상조(P<0.05)。결론:사용ZBPYR치료적대서NMDAR mRNA적표체수평재각뇌구균명현상조,저표명ZBPYR이제승NMDAR mRNA적방식,사득NMDAR단백적함량현저증다,이발휘기항치태작용。
This study was aimed to observe the effect ofZi-Bu Pi-Yin Recipe (ZBPYR) on the mRNA expressions of NMDA receptor subunits NR1, NR2A, NR2B in different brain regions of spleen-yin deficiency Alzheimer's Disease (AD) model rats. The levels of NR1, NR2A, NR2B mRNA expressions were detected by using RT-PCR method. The results showed that the levels of NR1, NR2A, NR2B mRNA expressions of AD group and spleen-yin deficiency AD group decreased significantly (P < 0.05). The levels of NR1, NR2A, NR2B mRNA expressions of ZBPYR treatment group increased significantly (P < 0.05). It was concluded that the expression levels of NMDAR mRNA in different brain regions of the ZBPYR treatment group increased significantly, which indicated that ZBPYR may up-regulate the protein expressions of NMDAR by increasing the expression levels of NMDAR mRNA, thereby to play the anti-dementia effect.